Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 33 Records) |
| Query Trace: Breast Neoplasms and NQO1[original query] |
|---|
| Oral contraceptive use and breast cancer risk: modification by NAD(P)H:quinone oxoreductase (NQO1) genetic polymorphisms. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2004 Aug 13 (8): 1308-15. Fowke Jay H, Shu Xiao-Ou, Dai Qi, Jin Fan, Cai Qiuyin, Gao Yu-Tang, Zheng W |
| Breast cancer: role of polymorphisms in biotransformation enzymes. European journal of human genetics : EJHG 2004 Oct 12 (10): 848-54. Sarmanová Jana, S?sová Simona, Gut Ivan, Mrhalová Marcela, Kodet Roman, Adámek Jan, Roth Zdenek, Soucek Pav |
| Association of NQO1 polymorphism with spontaneous breast cancer in two independent populations. British journal of cancer 2004 May 90 (10): 1989-94. Menzel H-J, Sarmanova J, Soucek P, Berberich R, Grünewald K, Haun M, Kraft H |
| Genetic variability in iron-related oxidative stress pathways (Nrf2, NQ01, NOS3, and HO-1), iron intake, and risk of postmenopausal breast cancer. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2007 Sep 16 (9): 1784-94. Hong Chi-Chen, Ambrosone Christine B, Ahn Jiyoung, Choi Ji-Yeob, McCullough Marjorie L, Stevens Victoria L, Rodriguez Carmen, Thun Michael J, Calle Eugenia |
| Role of MTHFR (677, 1298) haplotype in the risk of developing secondary leukemia after treatment of breast cancer and hematological malignancies. Leukemia 2007 Jul 21 (7): 1413-22. Guillem V M, Collado M, Terol M J, Calasanz M J, Esteve J, Gonzalez M, Sanzo C, Nomdedeu J, Bolufer P, Lluch A, Tormo |
| NAD(P)H:quinone oxidoreductase 1 NQO1*2 genotype (P187S) is a strong prognostic and predictive factor in breast cancer. Nature genetics 2008 Jul 40 (7): 844-53. Fagerholm Rainer, Hofstetter Barbara, Tommiska Johanna, Aaltonen Kirsimari, Vrtel Radek, Syrjäkoski Kirsi, Kallioniemi Anne, Kilpivaara Outi, Mannermaa Arto, Kosma Veli-Matti, Uusitupa Matti, Eskelinen Matti, Kataja Vesa, Aittomäki Kristiina, von Smitten Karl, Heikkilä Päivi, Lukas Jiri, Holli Kaija, Bartkova Jirina, Blomqvist Carl, Bartek Jiri, Nevanlinna He |
| Phase II study of sequentially administered low-dose mitomycin-C (MMC) and irinotecan (CPT-11) in women with metastatic breast cancer (MBC). Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008 Aug 19 (8): 1417-22. Mrozek E, Kolesar J, Young D, Allen J, Villalona-Calero M, Shapiro C |
| Nitric oxide synthase variants and disease-free survival among treated and untreated breast cancer patients in a Southwest Oncology Group clinical trial. Clinical cancer research : an official journal of the American Association for Cancer Research 2009 Aug 15 (16): 5258-66. Choi Ji-Yeob, Barlow William E, Albain Kathy S, Hong Chi-Chen, Blanco Javier G, Livingston Robert B, Davis Warren, Rae James M, Yeh I-Tien, Hutchins Laura F, Ravdin Peter M, Martino Silvana, Lyss Alan P, Osborne C Kent, Abeloff Martin D, Hayes Daniel F, Ambrosone Christine |
| NAD(P)H:quinone oxidoreductase 1 Pro187Ser polymorphism and expression do not cosegregate with clinico-pathological characteristics of human mammary tumors. Pharmacogenetics and genomics 2009 Jul 19 (7): 505-12. Hubackova Miluse, Vaclavikova Radka, Mrhalova Marcela, Kubackova Katerina, Kodet Roman, Gut Ivan, Soucek Pav |
| Genetic polymorphisms of estrogen metabolizing enzyme and breast cancer risk in Thai women. International journal of cancer. Journal international du cancer 2009 Aug 125 (4): 837-43. Sangrajrang Suleeporn, Sato Yasunori, Sakamoto Hiromi, Ohnami Sumiko, Laird Nan M, Khuhaprema Thiravud, Brennan Paul, Boffetta Paolo, Yoshida Teruhi |
| Association between mitochondrial DNA 4,977 bp deletion and NAD(P)H:quinone oxidoreductase 1 C609T polymorphism in human breast tissues. Oncology reports 2009 May 21 (5): 1169-74. Tseng Ling-Ming, Yin Pen-Hui, Tsai Yi-Fang, Chi Chin-Wen, Wu Chew-Wun, Lee Liang-Ming, Lee Hsin-Ch |
| CASP8 D302H polymorphism delays the age of onset of breast cancer in BRCA1 and BRCA2 carriers. Breast cancer research and treatment 2010 Jan 119 (1): 87-93. Palanca Suela Sarai, Esteban Cardeñosa Eva, Barragán González Eva, de Juan Jiménez Inmaculada, Chirivella González Isabel, Segura Huerta Angel, Guillén Ponce Carmen, Martínez de Dueñas Eduardo, Montalar Salcedo Joaquín, Castel Sánchez Victoria, Bolufer Gilabert Pascual, |
| Evidence on the association between NQO1 Pro187Ser polymorphism and breast cancer risk in the current studies: a meta-analysis. Breast cancer research and treatment 2011 Jan 125 (2): 467-72. Yuan Weiguang, Xu Lidan, Chen Wangyang, Wang Lihong, Fu Zhenkun, Pang Da, Li Dianj |
| Two minor NQO1 and NQO2 alleles predict poor response of breast cancer patients to adjuvant doxorubicin and cyclophosphamide therapy. Pharmacogenetics and genomics 2011 Dec 21 (12): 808-19. Jamieson David, Cresti Nicola, Bray Johanne, Sludden Julieann, Griffin Melanie J, Hawsawi Nahed M, Famie Eve, Mould Emily V A, Verrill Mark W, May Felicity E B, Boddy Alan |
| Association of superoxide dismutases and NAD(P)H quinone oxidoreductases with prognosis of patients with breast carcinomas. International journal of cancer. Journal international du cancer 2012 Jan 130 (2): 338-48. Hubackova Miluse, Vaclavikova Radka, Ehrlichova Marie, Mrhalova Marcela, Kodet Roman, Kubackova Katerina, Vrána David, Gut Ivan, Soucek Pav |
| Polymorphism of xenobiotic-metabolizing genes and breast cancer susceptibility in North Indian women. Genetic testing and molecular biomarkers 2011 May 15 (5): 343-9. Singh Virendra, Upadhyay Ghanshyam, Rastogi Neeraj, Singh Kalpana, Singh Mahendra Prat |
| Analysis of functional germline polymorphisms for prediction of response to anthracycline-based neoadjuvant chemotherapy in breast cancer. Molecular genetics and genomics : MGG 2012 Sep 287 (9): 755-64. Szkandera Joanna, Absenger Gudrun, Dandachi Nadia, Regitnig Peter, Lax Sigurd, Stotz Michael, Samonigg Hellmut, Renner Wilfried, Gerger Arm |
| Association between polymorphisms in apoptotic genes and susceptibility for developing breast cancer in Syrian women. Breast cancer research and treatment 2013 Apr 138 (2): 611-9. Lajin Bassam, Alhaj Sakur Amir, Alachkar Am |
| Polymorphisms in oxidative stress-related genes and mortality in breast cancer patients--potential differential effects by radiotherapy? Breast (Edinburgh, Scotland) 2013 Mar . Seibold P, Hall P, Schoof N, Nevanlinna H, Heikkinen T, Benner A, Liu J, Schmezer P, Popanda O, Flesch-Janys D, Chang-Claude J |
| Pharmacogenetics of adjuvant breast cancer treatment with cyclophosphamide, epirubicin and 5-fluorouracil. Cancer chemotherapy and pharmacology 2014 Oct 74 (4): 667-74. Jamieson David, Lee Jo, Cresti Nicola, Jackson Rosanna, Griffin Melanie, Sludden Julieanne, Verrill Mark, Boddy Alan |
| The NQO1 Pro187Ser polymorphism and breast cancer susceptibility: evidence from an updated meta-analysis. Diagnostic pathology 2014 9 (1): 100. Peng Qiliu, Lu Yu, Lao Xianjun, Chen Zhiping, Li Ruolin, Sui Jingzhe, Qin Xue, Li Sh |
| Relationship of MTHFR and NQO1 Pharmacogenetics and Chemotherapy Clinical Outcomes in Breast Cancer Patients. Biochemical genetics 2015 Aug 53 (7-8): 211-22. Chaturvedi Pankaj, Tulsyan Sonam, Agarwal Gaurav, Lal Punita, Agrawal Sushma, Mittal Rama D, Mittal Balr |
| Generalized Multifactor Dimensionality Reduction (GMDR) Analysis of Drug-Metabolizing Enzyme-Encoding Gene Polymorphisms may Predict Treatment Outcomes in Indian Breast Cancer Patients. World journal of surgery 2015 Oct . Agarwal Gaurav, Tulsyan Sonam, Lal Punita, Mittal Balr |
| The C609T (Pro187Ser) Null Polymorphism of the NQO1 Gene Contributes Significantly to Breast Cancer Susceptibility in North Indian Populations: a Case Control Study. Asian Pacific journal of cancer prevention : APJCP 2016 17 (3): 1215-9. Yadav Prasant, Mir Rashid, Nandi Kajal, Javid Jamsheed, Masroor Mirza, Ahmad Imtiyaz, Zuberi Mariyam, Kaza Rcm, Jain Sk, Khurana Nita, Ray Prakash Chandra, Saxena Alpa |
| Glutathione S-transferases deletions may act as prognosis and therapeutic markers in breast cancer. Clinical and experimental medicine 2017 Apr . Campos Clodoaldo Zago, Losi Guembarovski Roberta, de Oliveira Carlos Eduardo Coral, Banin Hirata Bruna Karina, Vitiello Glauco Akelinghton Freire, Dias Flávia Luísa, Hiroki Carlos Hiroji, Watanabe Maria Angelica Ehara, Mazzuco Tânia Lon |
| Dissecting the prevention of estrogen-dependent breast carcinogenesis through Nrf2-dependent and independent mechanisms. OncoTargets and therapy 2019 8 12 4937-4953. Giudice Aldo, Barbieri Antonio, Bimonte Sabrina, Cascella Marco, Cuomo Arturo, Crispo Anna, D'Arena Giovanni, Galdiero Massimiliano, Della Pepa Maria Elena, Botti Gerardo, Caraglia Michele, Capunzo Mario, Arra Claudio, Montella Mauriz |
| Genetic polymorphisms on the effectiveness or safety of breast cancer treatment: Clinical relevance and future perspectives. Mutation research. Reviews in mutation research 2021 12 788 108391. Cura Yasmin, Pérez Ramírez Cristina, Sánchez Martín Almudena, Martínez Martínez Fernando, Calleja Hernández Miguel Ángel, Ramírez Tortosa María Del Carmen, Jiménez Morales Alber |
| Impact of xenobiotic-metabolizing gene polymorphisms on breast cancer risk in South Indian women. Breast cancer research and treatment 2021 Jan . Rajagopal Taruna, Seshachalam Arun, Rathnam Krishna Kumar, Jothi Arunachalam, Talluri Srikanth, Venkatabalasubramanian Sivaramakrishnan, Dunna Nageswara R |
High-throughput screening and genome-wide analyses of 44 anticancer drugs in the 1000 Genomes cell lines reveals an association of the NQO1 gene with the response of multiple anticancer drugs.
PLoS genetics 2021 8 17 (8): e1009732. Akhtari Farida S, Green Adrian J, Small George W, Havener Tammy M, House John S, Roell Kyle R, Reif David M, McLeod Howard L, Wiltshire Timothy, Motsinger-Reif Alison |
| Efficacy and safety of pegylated liposomal doxorubicin and epirubicin as neoadjuvant chemotherapy for breast cancer. Frontiers in cell and developmental biology 2025 1 12 1448037. Yuanyuan Shen, Qingling Hua, Menghao Dong, Wei Jin, Xueyang Hu, Kangsheng |
- Page last reviewed:Feb 1, 2024
- Content source: